Evidence map›Paper›PMID 33526003›Full record

ArticleJournal of biomolecular structure & dynamics2022

Flavonol morin targets host ACE2, IMP-α, PARP-1 and viral proteins of SARS-CoV-2, SARS-CoV and MERS-CoV critical for infection and survival: a computational analysis.

Anamika Gupta, Rumana Ahmad, Sahabjada Siddiqui, Kusum Yadav, Aditi Srivastava, Anchal Trivedi, Bilal Ahmad, Mohsin Ali Khan, Amit Kumar Shrivastava, Girish Kumar Singh

Open access · greenAbstract read
In one paragraph

Article in Journal of biomolecular structure & dynamics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Steroidal lactones fromIn silico pharmacology · 2024
    Article
  5. Article
  6. Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Anamika GuptaDepartment of Biochemistry, Era's Lucknow Medical College and Hospital, Era University, Lucknow, UP, India.
Rumana AhmadDepartment of Biochemistry, Era's Lucknow Medical College and Hospital, Era University, Lucknow, UP, India.
Sahabjada SiddiquiDepartment of Biotechnology, Era's Lucknow Medical College and Hospital, Era University, Lucknow, UP, India.
Kusum YadavDepartment of Biochemistry, University of Lucknow, Lucknow, UP, India.
Aditi SrivastavaDepartment of Biochemistry, Era's Lucknow Medical College and Hospital, Era University, Lucknow, UP, India.
Anchal TrivediDepartment of Biochemistry, Era's Lucknow Medical College and Hospital, Era University, Lucknow, UP, India.
Bilal AhmadResearch Cell, Era's Lucknow Medical College and Hospital, Era University, Lucknow, UP, India.
Mohsin Ali KhanChancellor, Era University, Lucknow, UP, India.
Amit Kumar ShrivastavaDepartment of Pharmacology, Universal College of Medical Sciences & Hospital, Ranigaon, Bhairahawa, Rupandehi, Nepal.
Girish Kumar SinghDepartment of Orthopedics, Era's Lucknow Medical College and Hospital, Era University, Lucknow, UP, India.
Era's Lucknow Medical College and Hospital · INUniversal College of Medical SciencesUniversity of Lucknow · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A sudden outbreak of a novel coronavirus SARS-CoV-2 in 2019 has now emerged as a pandemic threatening to efface the existence of mankind. In absence of any valid and appropriate vaccines to combat this newly evolved agent, there is need of novel resource molecules for treatment and prophylaxis. To this effect, flavonol morin which is found in fruits, vegetables and various medicinal herbs has been evaluated for its antiviral potential in the present study. PASS analysis of morin

Indexed as

COVID-19 Drug TreatmentMiddle East Respiratory Syndrome CoronavirusAngiotensin-Converting Enzyme 2Antiviral AgentsFlavonesFlavonoidsFlavonolsHumansMolecular Docking SimulationPoly(ADP-ribose) Polymerase InhibitorsSARS-CoV-2Viral ProteinsAngiotensin-Converting Enzyme 2Antiviral AgentsFlavonesFlavonoidsFlavonolsmorinPoly(ADP-ribose) Polymerase InhibitorsViral ProteinscoronavirusesCOVID-19flavonolsMERSmolecular dockingmorinSARSSARS-CoV-2

Identifiers

PMID33526003
PMCPMC7869441
OpenAlexW3126416050

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.